NASDAQ · Drug Manufacturers - Specialty & Generic

Cosmos Health Inc. (COSM) Stock

$0.35 +10.46% NASDAQ: COSM Healthcare

Valuation

MetricValue
Price$0.35
Market Cap$18.90M
P/E Ratio-0.58
P/B Ratio1.10
P/S Ratio0.28
EPS (TTM)$0.00
52-Week High$1.32
52-Week Low$0.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-118.89%
ROA-39.68%
ROCE-68.27%
Gross Margin-26.15%
Operating Margin-26.15%
Net Margin-33.08%
Debt/Equity0.77
Current Ratio1.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$56.0M$50.0M$53.0M$54.0M$65.0M
Operating Profit$-5.0M$-7.0M$-22.0M$-16.0M$-17.0M
Net Profit$-8.0M$-14.0M$-19.0M$-16.0M$-19.0M
EPS$-23.74$-33.16$-2.15$-1.17$-0.63
Op Margin-8.1%-14.8%-40.9%-28.6%-25.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$49.0M$68.0M$66.0M$54.0M$65.0M
Total Liabilities$45.0M$28.0M$30.0M$30.0M$47.0M
Cash$0$21.0M$4.0M$0$1.0M
Borrowings$27.0M$12.0M$12.0M$12.0M$20.0M

Latest News

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units GlobeNewswire · Jul 20, 2026 Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases GlobeNewswire · Jul 17, 2026 Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases GlobeNewswire · Jul 16, 2026 Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases GlobeNewswire · Jul 15, 2026 Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases GlobeNewswire · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-7.0M$-15.0M$-16.0M$-8.0M$-8.0M
Investing Cash Flow$-2.0M$0$-23.0M$-1.0M$-2.0M
Financing Cash Flow$0$8.0M$3.0M$10.0M$-2.0M
Net Cash Flow$0$20.0M$-17.0M$-4.0M$3.0M
Free Cash Flow$-8.0M$-15.0M$-25.0M$-8.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-1.79
FCF Yield-55.82%
Quick Ratio0.92
Interest Coverage-5.19
Return 1Y-38.11%
Return 3Y-90.78%
Return 5Y-93.95%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.71 -1.09% 38.93 $4.95T 0.32%
MSFTMicrosoft Corporation $535.72 +2.51% 28.68 $3.98T 0.76%
GOOGLAlphabet Inc. $352.57 +1.23% 16.94 $4.27T 0.26%
AMZNAmazon.com, Inc. $262.61 +3.37% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $719.65 -0.17% 27.93 $1.83T 0.28%

About Cosmos Health Inc.

Cosmos Health Inc. is led by CEO Grigorios Siokas, employs 149 people, headquartered in US, publicly traded since 2010.

Cosmos Health Inc. (COSM) stock trades at $0.35 with a market capitalization of $18.90M. The stock is valued at a price-to-earnings (P/E) ratio of -0.58, price-to-book of 1.10, price-to-sales of 0.28. Over the past 52 weeks the stock has ranged between $0.16 and $1.32, and currently trades 73.5% below its 52-week high.

On profitability, Cosmos Health Inc. generates a return on equity (ROE) of -118.89%, return on capital employed of -68.27%, an operating margin of -26.15%, a net profit margin of -33.08%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1175.87 +0.54% JNJ Johnson & Johnson $260.78 +1.68% ABBV AbbVie Inc. $276.48 +1.49% MRK Merck & Company, Inc. Common Stock (new) $146.30 +2.75% UNH UnitedHealth Group Incorporated Common Stock (DE) $381.94 +2.96% NVS Novartis AG $143.79 +0.47% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $658.24 +0.96% AMGN Amgen Inc. $415.91 +2.08% GILD Gilead Sciences, Inc. $150.59 +2.37% ABT Abbott Laboratories $99.58 +1.10% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides